Long-term adverse effects of therapy in patients cured of a childhood malignancy;Dlhodobé nežiaduce účinky terapie u pacientov vyliečených z detskej malignity

Klinicka Onkologie

Volumn 20, Issue 1, 2007, Pages 18-22

  Mladosievicova B ^a   Kaiserova E ^b   Foltinova A ^b   Petrasova H ^a  

^a Oddelenie Klinickej Patofyziologie   (Slovakia)

^b Detská Dermatovenerologická Klinika LFUK a DFNsP   (Slovakia)

Author keywords

Cancer therapy; Childhood cancer survivors; Guidelines for follow up; Late effects of therapy; Long term complications

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER RISK; CANCER SURVIVAL; CANCER THERAPY; CARDIOTOXICITY; CHILDHOOD CANCER; COGNITIVE DEFECT; ENDOCRINE DISEASE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; INFERTILITY; LONG TERM CARE; LUNG TOXICITY; METASTASIS; MUSCULOSKELETAL SYSTEM MALFORMATION; REVIEW;

EID: 33847068735     PISSN: 0862495X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Steliarova-Foucher E, Stiller C, Kaatsch P, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s: An epidemiological study. Lancet 2004; 11, 364(9451): 2097-2105
2. Bleyer WA, Tejeca H, Murphy SB, et al. The impact of childhood cancer on the United States and the world. CA Cancer J Clin 1990; 40: 355-367
3. Bajčiová V, Štěrba J, Mužík J, Kocák I. Co dlužíme dospívajícím a mladým dospělým s nádorovým onemocněním. Rezervy v komplexní onkologické péči o dospívajíci a mladé dospělé. Edukační zborník XXX. Brněnské onkologické dny. 126-127, 2006
4. Kepák T, Pavelka Z, Hrstková H, Šlampa P, Kiss I, Žaloudík J, Vorlíček J, Štěrba J. Dlouhodobá dispenzarizace po léčbě nádorových onemocnění v dětství v rǎmci Univerzitního onkologického centra. Klin Onkol 2002; 15 (6): 234
5. Kaiserová E, Bubánska E, Oravkinová I, et al. Cancer in adolescents: incidence and treatment in Slovak Republic. Pediat Blood Cancer 2005; 45(4): 492
6. Scottish Intercollegiate Guidelines Network (SIGN). Long term follow up of survivors of childhood cancer. Guideline no. 76. www.sign.ac.uk/pdf/sign76. pdf
7. Mertens A, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivors Study. J Clin Oncol 2001; 19 (13): 3163-3172
8. Oeffinger KC, Mertens AC, Sklar CA, et al. Prevalence and severity of chronic diseases in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2005; 23: 2
9. Schwartz C. Long-term survivors of childhood cancer: the late effects of therapy. Oncologist 1999; 4: 45-54
10. Bhatia S., Blatt J., Meadows A.T.: Late effects of childhood cancer and its treatment. In: Pizzo PA, Poplack DG: Principles and Practice of Pediatric Oncology. 5. vyd. Philadelphia, USA, Lippincott Williams & Wilkins, 1490-1514, 2006
11. Bhatia S., Meadows A.T.: Long-term follow-up of childhood cancer survivors: future directions for clinical care and research. Pediatr Blood Cancer 2006; 46: 143-148
12. Garré ML, Cesana B, et al. Health status of long-term survivors after cancer in childhood. Am J Pediatr Hematol Oncol 1994; 16: 143-152
13. Lin HMJ, Teitell MA. Second malignancy after treatment of pediatric Hodgkin's disease. J Pediatr Hematol Oncol 2005; 27(1): 28-35
14. Oeffinger KC, Eshelman DA, Tomlinson GE, et al. Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting. Cancer 2000; 88: 1687-1695
15. Oeffinger KC, Eshelman DA, Tomlinson GE, et al. Providing primary care for long-term survivors of childhood acute lymphoblastic leukemia. J Fam Pract 2000; 49: 1133-1146
16. Vyzula R, Vorlíček J. Komplikácie multimodálnej terapie a podporná liečba v onkológii, s. 505-575, In. Jurga L', et al. Klinická onkológia a rádioterapia, SAP, 2000.
17. Hewitt M, Greenfield S, Stovall E (eds): From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC, The National Academy Press, 2005
18. Čáp J, Foltinová A, Bohunický L'. Výsledky dlhodobého sledovania detí s Hodgkinovou chorobou. Klin Onkol 1990; 3: 84-88
19. Radvanský J, Radvanská J, Slabý K, et al. Pozdní následky Hodgkinovy choroby a její léčby u pacientů léčených v letech 1980-1999 na Klinice dětské onkologie UK 2. LF a FNM. Klin Onkol 2004; 17 (4): 131-135
20. Children's Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancer. Version 2.0. 2006. www.survivorshipguidelines.org
21. Schwartz CL, Hobbie WL, Constine LS, Ruccione KS. Survivors of childhood and adolescent cancer. 2nd ed, Springer-Verlag Berlin Heidelberg, Germany, 2005, 348 s.
22. Muss HB, Von Roenn J, Damon LE: ACCO: ASCO Core Curriculum Outline. J Clin Oncol 23:2049-2077, 2005
23. Earle EA, Davies H, Greenfield D, et al. Follow-up care for childhood cancer survivors: a focus group analysis. Eur J Cancer 2005 Dec; 41(18): 2882-2886
24. Meadows AT, Black B, Nesbit ME jr, et al. Long-term survival. Clinical care, research and education. Cancer 1993; 71, 3213-3215
25. Oeffinger KC, Wallace WHB. Barriers to follow-up care of survivors in the United States and the United Kingdom. Pediatr Blood Cancer 2006; 46: 135-142
26. Mladosievičová B, Foltinová A, Wawruch M. Genetické testy v predikcii účinnosti a toxicity chemoterapie u onkologickych pacientov. Vnitř lék 2005; 51(5): 560-565
27. Travis LB, Rabkin CS, Brown LM, et al. Cancer survivorship-genetic- susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst 2006 Jan 4; 98(1): 15-25
28. Ulrich CM, Robien K, McLeod HL. Cancer pharmacogenetics: polymorphisms, pathways and beyond. Nat Rev Cancer 2003; 3(12): 912-920
29. Kadan-Lottick NS, Robison LL, Gurney JG, et al. Childhood Cancer Survivors' Knowledge About Their Past Diagnosis and Treatment. Childhood Cancer Survivor Study. JAMA 2002; 287(14): 1832-1839